A recent study presented at the European Obesity Conference suggests that combining weight loss drugs with behavioral programs reduces intrusive thoughts about food to a greater extent than behavioral therapy alone. The study results provide evidence that drugs known as glucagon-like peptide-1 receptor agonists can help quiet the constant mental chatter about eating. Related research published in journals obesity We outline the creation of a new tool to measure these sustained thoughts.
Many people trying to manage their weight report having a constant mental dialogue about what, when, and how much to eat. Scientists call this phenomenon food noise. This concept involves persistent and intrusive thoughts about food that disrupt daily life and make it difficult to make healthy choices.
Patients describe this experience as a constant stream of food-related thoughts, even when they are not physically hungry. They may spend a large portion of their day planning their next meal or worrying about what they recently ate. These thoughts can easily distract you from work, family, and daily responsibilities. Historically, this cognitive aspect of weight management has been difficult to measure because it is a completely internal experience.
Recently, a class of drugs called glucagon-like peptide-1 receptor agonists has received widespread attention for the treatment of obesity. These drugs mimic natural hormones in the body that help regulate appetite and blood sugar levels. Patients using these drugs frequently report a sudden and dramatic reduction in their mental chatter about food.
Based on these personal accounts, the researchers wanted to test whether these drugs actually reduce eating noise more effectively than traditional behavioral treatments. Behavioral therapy typically includes digital or in-person programs that encourage dietary and exercise modifications. To conduct this kind of research, scientists first needed a reliable way to measure mental chatter.
Until recently, no validated research existed to quantify how often people experience such intrusive thoughts. This gap in measurement tools led initial studies to develop and test standard questionnaires. The scientists aimed to create a tool that could be easily used both in clinical practice and in future experiments.
To create this measurement tool, the authors of the paper published in *Obesity* first consulted nine experts to consider potential questions. They refined the wording to accurately capture the destructive nature of food-related thoughts. We also adjusted the language so that the findings read at a fourth-grade reading level, making them highly accessible to the general public.
The team then recruited 400 adults to take part in an online survey. Participants reported their demographic information, height, weight, and diet history. The final analysis included 396 individuals who successfully answered all survey questions.
Most participants in this research and development group were white women. The mean age was approximately 51 years, and the mean BMI was 31. BMI is a standard calculation based on height and weight used to classify a person’s body size.
The original survey included seven items, but the researchers removed two redundant questions. The final survey asks participants to rate their agreement with five statements on a scale of 0 to 4. These statements include concepts such as constantly thinking about food, feeling unable to control those thoughts, and being distracted by food.
The total score ranges from 0 to 20, with higher scores indicating more severe food noise. To test whether the study was consistent, 150 participants completed the survey again seven days later. Scores remained highly consistent over the week, suggesting this tool is a reliable scientific measure.
The remaining 250 participants completed additional surveys measuring depression, stress, and anxiety. This step helped to verify that the new questionnaire was measuring unique concepts rather than general mental health issues. Good psychological research must demonstrate that it is not incorrectly measuring a completely different condition. Scientists found that the tool accurately measures eating noise as a unique experience, distinguishing it from common anxiety and mood disorders.
The research team also noticed some interesting demographic trends in the survey data. Women tended to score higher than men, and those who were actively dieting reported having more intrusive thoughts about food. Participants with higher BMI also reported higher noise levels while eating. In contrast, retired individuals and adults aged 55 and older reported lower scores.
Now that a reliable tool was established, researchers tested how weight loss drugs affect these beliefs in a clinical setting. This observational study included 417 adults enrolled in a digital behavioral weight management program. The researchers used a newly validated questionnaire to collect data at the beginning of the study and one month later.
The sample included 92 participants who started taking a glucagon-like peptide-1 drug in parallel with a behavioral program. An additional 325 participants participated in the behavioral program without taking medication. Researchers excluded people who were already using weight loss drugs at the start of the program.
Most participants in this medication study were white and female. The mean age was 59 years, and the mean BMI was 34. Scientists used a statistical model to compare how scores changed over the course of a month between the two groups.
To ensure a fair comparison, the researchers adjusted the statistical model to account for participants’ starting scores. At the start of the study, adjusted scores for both groups were around 11 out of 20. After a month, both groups experienced a decrease in eating noise.
Participants who used only the behavioral program had an adjusted mean score reduction of 1 point and 2 points. Even greater reductions were seen in participants who took the medication at the same time as the behavioral program. The medication group saw a decrease of just over 4 points on the survey.
When comparing the two groups, drug users’ scores decreased by a significant 3 points. This difference provides evidence that the drug significantly quiets persistent thoughts about food compared to behavioral changes alone. The authors suggest that this early decline in mental chatter may indicate how well patients are responding to treatment.
Although these findings are informative, there are some limitations that should be considered. The study that looked at drug use only followed participants for one month. Because this period is short, it is unclear whether the reduction in intrusive thoughts persists over time.
The researchers note that future studies will need to test patients over several months or years. Tracking long-term changes could help scientists understand how reducing mental chatter about food affects overall health and weight loss success. Longer-term studies will also determine whether thinking returns when patients stop taking the drug.
Another limitation is the demographic composition of both studies. Participants in both samples were primarily Caucasian and female. Future studies should include more diverse groups to see if the results apply equally to men and people from different racial and ethnic backgrounds.
Additionally, this medication study was observational rather than a randomized controlled trial. This means participants chose whether to take the drug or not, which could introduce bias in some cases. A randomized controlled trial is a type of research in which participants are randomly assigned to different treatments, resulting in stronger scientific evidence. The authors suggest that such trials are needed to confirm these initial findings.
Finally, the researchers plan to further investigate the relationship between actual weight loss and reduced mental chatter. Analyzing how changes in weight correspond to changes in thought patterns will be an important next step for the scientific community. Exploring this connection may provide new ways to support patients on their weight management journey. This future research may reveal whether quieting the mind is a necessary step to achieving long-term physical changes.
The study, “Changes in food noise in two weight management programs: Effects of GLP-1 receptor agonists,” was authored by Hanim E. Diktas, Stephanie P. Goldstein, Michelle I. Cardel, Gary D. Foster, and Corby K. Martin.
The study, “Development and Validation of the Food Noise Questionnaire,” was authored by Hanim E. Diktas, Michelle I. Cardel, Gary D. Foster, Monique M. LeBlanc, Stephanie L. Dickinson, Erin M. Ables, Xiwei Chen, Rebecca Nathan, Danielle Shapiro, and Corby K. Martin.
